Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Total Current Liabilities: 2021-2022

Historic Total Current Liabilities for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $7.4 million.

  • Cardiol Therapeutics' Total Current Liabilities rose 262.04% to $7.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $7.4 million, marking a year-over-year increase of 262.04%. This contributed to the annual value of $9.2 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Cardiol Therapeutics reported Total Current Liabilities of $7.4 million as of Q3 2022, which was down 17.03% from $8.9 million recorded in Q2 2022.
  • Over the past 5 years, Cardiol Therapeutics' Total Current Liabilities peaked at $9.2 million during Q4 2021, and registered a low of $2.0 million during Q3 2021.
  • Over the past 2 years, Cardiol Therapeutics' median Total Current Liabilities value was $7.7 million (recorded in 2022), while the average stood at $6.3 million.
  • Data for Cardiol Therapeutics' Total Current Liabilities shows a peak YoY surged of 274.35% (in 2022) over the last 5 years.
  • Cardiol Therapeutics' Total Current Liabilities (Quarterly) stood at $9.2 million in 2021, then skyrocketed by 262.04% to $7.4 million in 2022.
  • Its Total Current Liabilities stands at $7.4 million for Q3 2022, versus $8.9 million for Q2 2022 and $8.0 million for Q1 2022.